Pilot Prospective Cohort Study to Define Biomarkers of Aging | Dr. Rashi Jain
Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.
Verlauf & EmpfehlungenAus
Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.
Merkliste & Verlauf öffnen →Über dieses Video
Creator-Beschreibung · OriginaltextTextsprache: Englisch
In this talk, Dr. Rashi Jain, AIIMS Delhi, presents a pilot cohort study exploring biomarkers of aging across five life stages—from newborns to adults over 80 years. The study examines biological markers linked to the 12 hallmarks of aging, alongside cognitive, physiological, dietary, and functional assessments.
Conducted at the National Centre of Ageing, AIIMS New Delhi, the research tracks participants across different age cohorts and will follow them over five years to better understand the pace of biological aging. By combining clinical assessments with molecular biomarkers such as telomere length and epigenetic changes, the study aims to provide deeper insights into how aging unfolds across the human lifespan.
This work represents one of the first efforts from India to systematically study biological aging biomarkers across multiple generations, with the potential to inform future approaches to longevity research and personalized healthcare.
🔔 Subscribe and stay tuned!
More:
🌐Longevity India: https://linktr.ee/longevity.india
Aging is something we all experience — in our families, our parents, and ourselves. We often talk about it, but we rarely record it. At Longevity India, we’re trying to change that. Through a few simple questions, we’re trying to capture what aging looks like in Indian homes: our diets, health habits, and everyday lives.
Take the surveys here: https://lnk.bio/LongevityIndiaSurveys
Longevity India · 14 min · Quelle veröffentlicht: 2026-03-03
Zu Harbor hinzugefügt: 23.10.2026
Original auf YouTube ↗Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.